Genitourinary Radiology: Page 4

Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

By AuntMinnieEurope.com staff writers

Blue Earth Therapeutics has secured an "innovation passport" from the U.K.'s Innovative Licensing and Access Pathway for its investigational therapeutic radiopharmaceutical lutetium-177 rhPSMA-10.1 for treatment of metastatic prostate cancer.

November 8, 2022

Quibim secures CE mark for QP-Prostate

By AuntMinnieEurope.com staff writers

Quibim has secured the CE mark for QP-Prostate as a class IIB device, as well as receiving UKCA certification.

October 27, 2022

MR-guided biopsies and transurethral ablation give hope in prostate care

By Mélisande Rouger

PARIS -- Clinical advances in MRI-guided percutaneous diagnosis and emerging treatment options for prostate tumors were discussed in depth during a special session at the French national radiology congress, JFR 2022.

October 10, 2022

Spotlight falls on cancer detection rates in prostate MRI

By Philip Ward

Dynamic contrast enhancement can help identify clinically significant cancers in prostate multiparametric MRI at 1.5 tesla, but the effect is smaller at 3 tesla and there is a higher risk of overdiagnosis due to detection of additional low-risk cancers, German researchers have reported.

September 14, 2022

Novel ultrasound method can boost prostate cancer risk assessment

By Amerigo Allegretto

A nomogram prediction model that uses contrast-enhanced ultrasound can help predict prostate cancer risk, a new study has found. The authors hope the new technique will lead to a meaningful reduction in unnecessary biopsies.

August 4, 2022

Microultrasound compares well with MRI on prostate cancer detection

By Amerigo Allegretto

Microultrasound has detection rates for prostate cancer that are comparable to multiparametric MRI in men who have not yet been biopsied, researchers have reported in a study published on 19 July in Radiology.

July 20, 2022

ECR: CT radiomics can aid in characterizing renal cysts

By Erik L. Ridley

VIENNA - The combination of CT radiomics and a machine-learning algorithm can help predict if a renal cyst is benign or malignant, potentially helping to avoid unnecessary surgeries, research presented at ECR 2022 indicates.

July 16, 2022

ECR: How has COVID affected cancer screening programs in Europe?

By Kate Madden Yee

VIENNA - The COVID-19 pandemic dramatically affected how healthcare was delivered in Europe, and oncology screening programs were not immune from its impact, according to a panel of experts that convened on 13 July at ECR 2022.

July 12, 2022

PET/CT compares well with MRI for prostate cancer detection

By Kate Madden Yee

Prostate-specific membrane antigen-PET/CT imaging is comparable to MRI for detecting clinically significant prostate cancer. But MRI is still the more accurate modality for determining the grade of disease, according to the results of a new study.

July 6, 2022

Support grows for modifying advice on prostate biopsies

By AuntMinnieEurope.com staff writers

Physicians at this week's UK Imaging & Oncology Congress in Liverpool have called for the National Institute for Health and Care Excellence to change its guidance on how prostate biopsies are conducted.

July 5, 2022

Echosens, Novo Nordisk partner on liver disease campaign

By AuntMinnieEurope.com staff writers

Echosens and Novo Nordisk are partnering on research support for early diagnosis of nonalcoholic steatohepatitis, as well as increased awareness of the disease.

June 26, 2022

SFR pays tribute to ultrasound pioneer Jean-Francois Moreau

By AuntMinnieEurope.com staff writers

The French Society of Radiology, SFR, is remembering radiologist Prof. Jean-Francois Moreau, who spent most of his career at Paris Descartes University, also known as Paris V. Moreau recently died at the age of 85.

June 26, 2022

Previous Page

Page 4 of 22

Next Page